EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 28 / No 4 (Avril 2012) Med Sci (Paris), 28 4 (2012) 381-387 References
Free Access
Issue
Med Sci (Paris)
Volume 28, Number 4, Avril 2012
Page(s) 381 - 387
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2012284015
Published online 25 April 2012
  1. Aylon Y, Oren M. New plays in the p53 theater. Curr Opin Genet Dev 2011 ; 21 : 86–92. [CrossRef] [PubMed] [Google Scholar]
  2. Belyi VA, Ak P, Markert E, et al. The origins and evolution of the p53 family of genes. Cold Spring Harb Perspect Biol 2010 ; 2 : a001198. [CrossRef] [PubMed] [Google Scholar]
  3. Khoury MP, Bourdon JC. p53 Isoforms: an intracellular microprocessor? Genes Cancer 2011 ; 2 : 453–465. [CrossRef] [PubMed] [Google Scholar]
  4. Meyer G. p73: a complex gene for building a complex brain. Cell Cycle 2011 ; 10 : 1188–1189. [CrossRef] [PubMed] [Google Scholar]
  5. Melino G. p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53. Cell Death Differ 2011 ; 18 : 1487–1499. [CrossRef] [PubMed] [Google Scholar]
  6. Rinne T, Brunner HG, van Bokhoven H. p63-associated disorders. Cell Cycle 2007 ; 6 : 262–268. [CrossRef] [PubMed] [Google Scholar]
  7. Rostagno P, Wolchinsky Z, Vigano AM, et al. Embryonic stem cells as an ectodermal cellular model of human p63-related dysplasia syndromes. Biochem Biophys Res Commun 2010 ; 395 : 131–135. [CrossRef] [PubMed] [Google Scholar]
  8. Mills AA, Zheng B, Wang XJ, et al. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999 ; 398 : 708–713. [CrossRef] [PubMed] [Google Scholar]
  9. Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999 ; 398 : 714–718. [CrossRef] [PubMed] [Google Scholar]
  10. Gambaro K, Aberdam E, Virolle T, et al. BMP-4 induces a Smad-dependent apoptotic cell death of mouse embryonic stem cell-derived neural precursors. Cell Death Differ 2006 ; 13 : 1075–1087. [Google Scholar]
  11. Medawar A, Virolle T, Rostagno P, et al. DeltaNp63 is essential for epidermal commitment of embryonic stem cells. PLoS One 2008 ; 3 : e3441. [CrossRef] [PubMed] [Google Scholar]
  12. Aberdam E, Barak E, Rouleau M, et al. A pure population of ectodermal cells derived from human embryonic stem cells. Stem Cells 2008 ; 26 : 440–444. [Google Scholar]
  13. Shalom-Feuerstein R, Lena AM, Zhou H, et al. ΔNp63 is an ectodermal gatekeeper of epidermal morphogenesis. Cell Death Differ 2011 ; 18 : 887–896. [CrossRef] [PubMed] [Google Scholar]
  14. Lo Iacono N, Mantero S, Chiarelli A, et al. Regulation of Dlx5 and Dlx6 gene expression by p63 is involved in EEC and SHFM congenital limb defects. Development 2008 ; 135 : 1377–1388. [CrossRef] [PubMed] [Google Scholar]
  15. Rouleau M, Medawar A, Hamon A, et al. TAp63 is important for cardiac differentiation of embryonic stem cells and heart development. Stem Cells 2011 ; 29 : 1672–1683. [CrossRef] [PubMed] [Google Scholar]
  16. Su X, Paris M, Gi YJ, et al. TAp63 prevents premature aging by promoting adult stem cell maintenance. Cell Stem Cell 2009 ; 5 : 64–75. [CrossRef] [PubMed] [Google Scholar]
  17. Rouleau M, Pucéat M, Aberdam D. Fonction inattendue de p63 dans le développement cardiaque : un phénotype peut en cacher un autre. Med Sci (Paris) 2011 ; 27 : 905–909. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  18. Gressner O, Schilling T, Lorenz K, et al. TAp63 induces apoptosis by activating signaling via death receptors and mitochondria. EMBO J 2005 ; 24 : 2458–2471. [CrossRef] [PubMed] [Google Scholar]
  19. Petitjean A, Cavard C, Shi H, et al. The expression of TA and DeltaNp63 are regulated by different mechanisms in liver cells. Oncogene 2005 : 24 : 512–519. [CrossRef] [PubMed] [Google Scholar]
  20. Petitjean A, Ruptier C, Tribollet V, et al. Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73. Carcinogenesis 2008 ; 29 : 273–281. [CrossRef] [PubMed] [Google Scholar]
  21. Flores ER, Tsai KY, Crowley D, et al. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 2002 ; 416 : 560–564. [CrossRef] [PubMed] [Google Scholar]
  22. Wu G, Osada M, Guo Z, et al. DeltaNp63alpha up-regulates the Hsp70 gene in human cancer. Cancer Res 2005 ; 65 : 758–766. [PubMed] [Google Scholar]
  23. Suh EK, Yang A, Kettenbach A, et al. p63 protects the female germ line during meiotic arrest. Nature 2006 ; 444 : 624–628. [CrossRef] [PubMed] [Google Scholar]
  24. Gonfloni S, Di Tella L, Caldarola S, et al. Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death. Nat Med 2009 ; 15 : 1179–1185. [CrossRef] [PubMed] [Google Scholar]
  25. Beyer U, Moll-Rocek J, Moll UM, Dobbelstein M. Endogenous retrovirus drives unknown proapoptotic p63 isoforms in the male germ line of humans and great apes. Proc Natl Acad Sci USA 2011 ; 108 : 3624–3629. [CrossRef] [Google Scholar]
  26. Truong AB, Kretz M, Ridky TW, et al. p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev 2006 ; 20 : 3185–3197. [CrossRef] [PubMed] [Google Scholar]
  27. Senoo M, Pinto F, Crum CP, McKeon F. p63 Is essential for the proliferative potential of stem cells in stratified epithelia. Cell 2007 ; 129 : 523–536. [CrossRef] [PubMed] [Google Scholar]
  28. Lechler T, Fuchs E. Asymmetric cell divisions promote stratification and differentiation of mammalian skin. Nature 2005 ; 437 : 275–280. [CrossRef] [PubMed] [Google Scholar]
  29. Lena AM, Shalom-Feuerstein R, Rivetti di Val Cervo P, et al. miR-203 represses stemness by repressing DeltaNp63. Cell Death Differ 2008 ; 15 : 1187–1195. [CrossRef] [PubMed] [Google Scholar]
  30. Yi R, Poy MN, Stoffel M, Fuchs E. A skin microRNA promotes differentiation by repressing stemness. Nature 2008 ; 452 : 225–229. [CrossRef] [PubMed] [Google Scholar]
  31. Carroll DK, Brugge JS, Attardi LD. p63, cell adhesion and survival. Cell Cycle 2007 ; 6 : 255–261. [CrossRef] [PubMed] [Google Scholar]
  32. Graziano V, De Laurenzi V. Role of p63 in cancer development. Biochim Biophys Acta 2011 : 1816 : 57–66. [PubMed] [Google Scholar]
  33. Ruptier C, De Gaspéris A, Ansieau S, et al. TP63 P2 promoter functional analysis identifies β-catenin as a key regulator of ΔNp63 expression. Oncogene 2011 ; 30 : 4656–4665. [CrossRef] [PubMed] [Google Scholar]
  34. Nylander K, Coates PJ, Hall PA. Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions. Int J Cancer 2000 ; 87 : 368–372. [CrossRef] [PubMed] [Google Scholar]
  35. Saintigny P, El-Naggar AK, Papadimitrakopoulou V, et al. DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia. Clin Cancer Res 2009 ; 15 : 6284–6291. [CrossRef] [PubMed] [Google Scholar]
  36. Flores ER, Sengupta S, Miller JB, et al. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 2005 ; 7 : 363–373. [CrossRef] [PubMed] [Google Scholar]
  37. Keyes WM, Vogel H, Koster MI, et al. p63 heterozygous mutant mice are not prone to spontaneous or chemically induced tumors. Proc Natl Acad Sci USA 2006 ; 103 : 8435–8440. [CrossRef] [Google Scholar]
  38. Su X, Chakravarti D, Cho MS, et al. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 2010 ; 467 : 986–990. [CrossRef] [PubMed] [Google Scholar]
  39. Caron de Fromentel C, Maguer-Satta V. Quand les mutants de p53 se livrent à des trafics ! Med Sci (Paris) 2010 ; 26 : 814–816. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  40. Ansieau S, Caron de Fromentel C, Bastid J, et al. Role of the epithelial-mesenchymal transition during tumor progression. Bull Cancer 2010 ; 97 : 7–15. [PubMed] [Google Scholar]
  41. Herfs M, Hubert P, Suarez-Carmona M, et al. Regulation of p63 isoforms by snail and slug transcription factors in human squamous cell carcinoma. Am J Pathol 2010 ; 176 : 1941–1949. [CrossRef] [PubMed] [Google Scholar]
  42. Adorno M, Cordenonsi M, Montagner M, et al. A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell 2009 ; 137 : 87–98. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.